Search results for: Institute for Clinical and Economic Review (ICER)
Filter search results
New Study of Time Lags in Translating Medical Research into Practice
30 November 2012
…the link between research and economic impact’ call for proposals. [2] Trochim, W., Kane, C., Graham, M. and Pincus, H.A. (2011) Evaluating translational research: A process marker model. Clinical and…
Adjusting Patient Case Mix to Compare PROMs across Providers
10 December 2013
…in a variety of activities such as “clinical audit, performance management, informing patient choice, monitoring productivity and assessing value for money”. Ensuring that such comparisons are valid, then, is essential….
Contracting for Quality in the NHS: 20th Annual Lecture Publication
28 January 2014
…of concern in the UK and elsewhere, as Professor Maynard explains. “Contracting for quality and patient protection in the NHS, and all other health care systems”, he concludes, “requires scepticism…
Biosimilars and HTA: Results of a Roundtable Discussion
9 April 2014
…MHRA; the three UK HTA entities, NICE and its Welsh (AWMSG) and Scottish (SMC) counterparts; and the UK industry trade association, the ABPI. Background for discussion at the meeting included…
Towse at ISPOR: Macro HTA and Managed Entry Agreements
7 October 2014
…that measures are based on formal written agreements about MEAs and PBRSAs that clearly set out expectations and responsibilities for all stakeholders. Managed Entry Agreements in Asia from Office of…
An Empirical Study of Two Alternative Comparators for Use in Time Trade-Off Studies
7 July 2015
…of an empirical health state valuation study carried out in collaboration between OHE and Brendan Mulhern of the University of Technology Sydney, Louise Longworth of Brunel University London, and Bas…
Professor Nancy Devlin Appointed to PHIN’s Board of Directors
9 October 2015
…to make better informed choices about their healthcare providers and, through the provision of comparative information, to help private providers to continuously improve their care and clinical outcomes. To achieve…
Just Published: OHE Report on Trends in Scottish Medicines Committee Advice Decisions
25 February 2016
…and processes. These were: the increased use of modifiers when assessing cost-effectiveness, the introduction of Patient and Clinical Expert (PACE) groups, and the increased use of Patient Access Schemes (PAS)…
Comparing the Cancer-Specific EORTC-8D and the Generic EQ-5D-3L
4 January 2017
…large-scale prospective longitudinal population-based molecular cancer cohort study from Victoria, Australia. In addition to clinical data and patient socio-demographics and familial history and participants self-completed patient reported outcome measures (PROMs)…